We are live on ! Find out more
VCYT icon

Veracyte

223 hedge funds and large institutions have $1.78B invested in Veracyte in 2022 Q4 according to their latest regulatory filings, with 48 funds opening new positions, 74 increasing their positions, 74 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

893% more call options, than puts

Call options by funds: $2M | Put options by funds: $201K

66% more first-time investments, than exits

New positions opened: 48 | Existing positions closed: 29

39% more capital invested

Capital invested by funds: $1.28B → $1.78B (+$499M)

7% more funds holding

Funds holding: 208223 (+15)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

0% more repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 74

1.85% less ownership

Funds ownership: 108.04%106.19% (-1.9%)

Holders
223
Holders Change
+15
Holders Change %
+7.21%
% of All Funds
3.58%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
48
Increased
74
Reduced
74
Closed
29
Calls
$2M
Puts
$201K
Net Calls
+$1.79M
Net Calls Change
-$3.18M
Name Holding Trade Value Shares
Change
Change in
Stake
EAM
51
Eagle Asset Management
Florida
$3.91M -$1.43M -61,695 -26%
EIM
52
Essex Investment Management
Massachusetts
$3.31M -$99.8K -4,296 -3%
Envestnet Asset Management
53
Envestnet Asset Management
Illinois
$3.31M +$231K +9,946 +8%
GIP
54
Granite Investment Partners
California
$3.07M -$1.15M -49,418 -28%
Citigroup
55
Citigroup
New York
$3.07M -$4.46M -191,716 -60%
TC
56
TwinBeech Capital
New York
$2.98M +$199K +8,549 +7%
SEI Investments
57
SEI Investments
Pennsylvania
$2.94M +$572K +24,621 +25%
PCM
58
Perkins Capital Management
Minnesota
$2.92M -$11.6K -500 -0.4%
Ameriprise
59
Ameriprise
Minnesota
$2.86M -$328K -14,131 -10%
PHP
60
Parkman Healthcare Partners
Connecticut
$2.79M +$1.32M +56,843 +93%
RhumbLine Advisers
61
RhumbLine Advisers
Massachusetts
$2.73M +$81.5K +3,508 +3%
LCG
62
Lisanti Capital Growth
New York
$2.67M +$2.61M +112,365 New
Qube Research & Technologies (QRT)
63
Qube Research & Technologies (QRT)
United Kingdom
$2.58M -$894K -38,487 -26%
Susquehanna International Group
64
Susquehanna International Group
Pennsylvania
$2.54M -$876K -37,706 -26%
Millennium Management
65
Millennium Management
New York
$2.5M +$2.2M +94,711 +881%
E
66
Ergoteles
New York
$2.37M +$2.32M +99,796 New
TI
67
Trexquant Investment
Connecticut
$2.3M +$837K +36,020 +59%
OAM
68
Oberweis Asset Management
Illinois
$2.19M +$2.15M +92,400 New
California State Teachers Retirement System (CalSTRS)
69
California State Teachers Retirement System (CalSTRS)
California
$2.16M +$24.7K +1,064 +1%
HF
70
HRT Financial
New York
$2.11M +$1.42M +61,002 +217%
Two Sigma Investments
71
Two Sigma Investments
New York
$2.11M -$1.45M -62,216 -41%
State of New Jersey Common Pension Fund D
72
State of New Jersey Common Pension Fund D
New Jersey
$2.09M -$431K -18,528 -17%
UBS AM
73
UBS AM
Illinois
$1.89M +$74.6K +3,209 +4%
SSA
74
Schonfeld Strategic Advisors
New York
$1.86M +$1.82M +78,300 New
AllianceBernstein
75
AllianceBernstein
Tennessee
$1.85M

VCYT Hedge Fund Activity: Q4 2022 in Review

223 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q4 2022, worth a combined $1.78B — up 39% from $1.28B a quarter earlier.

Buyers outnumbered sellers: 48 funds opened new VCYT positions and 29 closed out — a net gain of 19 holders — while 74 added to existing stakes and 74 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $18M. The largest seller was State Street, cutting an estimated $24.7M.

  • 223 institutional investors held Veracyte (VCYT) as of Q4 2022, up from 208 in Q3 2022.
  • Funds reported $1.78B of Veracyte stock for Q4 2022, up 39% quarter-over-quarter.
  • 48 funds opened new Veracyte positions in Q4 2022 and 29 closed out, a net change of +19 holders.
  • The largest Veracyte buyer in Q4 2022 was Wellington Management Group, an estimated $18M added.
  • The largest Veracyte seller in Q4 2022 was State Street, an estimated $24.7M sold.

Based on aggregated 13F filings for Q4 2022.